1. Catalogs
  2. PaxGenBio Co.,Ltd.
  3. PaxView® SARS-CoV-2 MPCR-ULFA Kit
video corpo

PaxView® SARS-CoV-2 MPCR-ULFA Kit

PaxView® SARS-CoV-2  MPCR-ULFA Kit

PaxView® SARS-CoV-2 MPCR-ULFA Kit

Product catalog summary
Overview: The PaxView® SARS-CoV-2 MPCR-ULFA Kit is an in vitro diagnostic tool designed for the qualitative detection of SARS-CoV-2 viral RNA in human upper respiratory specimens. It utilizes Multiplex PCR and Universal Lateral Flow Assay (MPCR-ULFA) technology for rapid and efficient testing.
Key Features:
  • Targets the Orf1ab (RdRp) and N genes for detection.
  • Includes an internal control through the amplification of the human RNase P gene.
  • One-step RT-PCR conducted in a single tube.
  • Prevents PCR carry-over contamination using UDG.
  • Compatible with all PCR thermocyclers.
  • User-friendly with results available in 10 minutes.
Advantages:
  • Multiplex molecular diagnostics combined with rapid diagnostic test technology.
  • Cost-effective and user-convenient.
  • Registered U.S. patent.
Procedure:
  • Sample collection and RNA extraction.
  • Amplification using MPCR.
  • Detection via ULFA.
Technical Specifications:
  • Package: 96 tests per kit.
  • Storage: MPCR at -25 ~ -15℃, ULFA at 15 ~ 30℃.
  • Expiration: 12 months.
Interpretation of Results:
  • Positive, Inconclusive, Negative, and Invalid results are visually interpreted.
Technology:
  • MPCR allows simultaneous detection of multiple pathogens.
  • ULFA provides rapid detection with visual results in 10 minutes.
  • Utilizes proprietary technology for DNA-DNA hybridization on NC membrane.
Contact Information: PaxGenBio Co., Ltd., 361, Simin-daero, Dongan-gu, Anyang-si, Gyeonggi-do, 14057, Republic of Korea. Phone: +82-31-244-5036, Email: [email protected], Website: www.paxgenbio.com
See more

Catalog excerpts

PaxView® SARS-CoV-2  MPCR-ULFA Kit-1

PaxView® SARS-CoV MPCR-ULFA KitDetection of COVID-19 causative virus SARS-CoV-2 PaxView® SARS-CoV-2 MPCR-ULFA Kit is an in vitro diagnostic kit designed for the qualitative detection of SARS-CoV-2 viral RNA in human upper respiratory specimens such as oropharyngeal or nasopharyngeal swabs through MPCR-ULFA (Multiplex PCR and Universal Lateral Flow Assay). Multiplex MDxUser Convenience •Target gene: Orf1ab (RdRp) and N gene • Monitor the entire process including the sample collection, RNA extraction, and RT-PCR through the amplification of the human RNase P gene as an internal control • One-step RT-PCR in a single tube • Prevention of PCR carry-over contamination with the use of UDG • All kinds of PCR thermocyclers are usable for the assay • User-friendly and convenient method • ULFA results in 10 minutes

 Open the catalog to page 1
PaxView® SARS-CoV-2  MPCR-ULFA Kit-2

PaxView® SARS-CoV-2 MPCR-ULFA Kit utilizes PaxGenBio’s proprietary technology. PCR primers amplifying target genes include the nucleotide sequence complementary to the universal probe immobilized on NC membrane. DNA-DNA hybridization between the probe and its complementary sequence of one end of PCR products with lateral flow assay enables detection of target genes. Proprietary technology MPCR-ULFA ■Multiplex PCR – ULFA (Universal Lateral Flow Assay) • Convergence of multiplex molecular diagnostics and rapid diagnostic test technology • Multiplex PCR amplification and DNA-DNA hybridization with...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.